DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.32, $0.01 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.02 billion.

GUIDANCE:

DexCom sees FY2025 revenue of $4.6 billion, versus the consensus of $4.606 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.